AXS-07 (MoSEIC meloxicam and rizatriptan)

Drug identity checked against registry records

Also recorded as AXS-07; MoSEIC meloxicam and rizatriptan

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Initiating Early Control of Migraine Pain and Associated SymptomsNCT04163185AXSMPhase 3Completed2020-03-16Actual
Maximizing Outcomes in Treating Acute MigraineNCT03896009AXSMPhase 3Completed2019-12-10Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.